Similarly, in another study, two patients with AFP+ tumor treated with an AFP-DNA vaccine followed by an adenovirus immune-boosting exhibited AFP-specific CD4+ and CD8+ T-cell–mediated cytotoxic response [169]. The gene discussed is CD8A; the disease is neoplasm.